Skip to main content
. 2023 Jan 19;14:1109747. doi: 10.3389/fendo.2023.1109747

Table 1.

Baseline characteristics of the study participant according to the quartiles of LXA4.

Variables LXA4 (ng/mL) P
Q1 (≤ 1.57) Q2 (1.57-2.24) Q3 (2.24-3.33) Q4 (> 3.33)
Age (years) 50.46 ± 5.98 49.96 ± 5.90 49.56 ± 6.05 49.69 ± 6.04 0.026
Male, n (%) 295 (42.8) 264 (39.1) 265 (38.7) 235 (33.3) 0.004
BMI (kg/m2) 23.97 ± 3.11 23.63 ± 2.78 23.81 ± 3.00 23.94 ± 2.99 0.124
WHR 0.88 ± 0.07 0.88 ± 0.08 0.88 ± 0.27 0.87 ± 0.07 0.717
SBP (mmHg) 124.72 ± 15.29 123.52 ± 15.56 123.51 ± 15.47 123.80 ± 14.67 0.420
DBP (mmHg) 78.01 ± 11.58 77.14 ± 11.22 77.31 ± 11.46 77.40 ± 11.06 0.527
Smoking, n (%) 194 (28.2) 180 (26.6) 174 (25.4) 150 (21.3) 0.022
Alcohol consumption, n (%) 138 (20.0) 126 (18.6) 134 (19.6) 106 (15.0) 0.066
Physical activity ≥ 4h/week 220 (31.9) 206 (30.5) 199 (29.1) 242 (34.3) 0.179
Family history of DM, n (%) 85 (12.3) 72 (10.7) 96 (14.0) 88 (12.5) 0.313
Hypertension, n (%) 283 (41.1) 230 (34.0) 266 (38.8) 283 (40.1) 0.037
Dyslipidemia, n (%) 226 (32.8) 213 (31.5) 225 (32.8) 250 (35.5) 0.460
Lipid-lowering drugs, n (%) 7 (1.0) 2 (0.3) 4 (0.6) 6 (0.9) 0.394
FPG (mmol/L) 5.49 ± 0.42 5.47 ± 0.39 5.46 ± 0.40 5.46 ± 0.39 0.478
TC (mmol/L) 4.90 ± 0.93 4.80 ± 0.87 4.84 ± 0.90 4.87 ± 0.90 0.213
TG (mmol/L) 1.40 ± 0.96 1.37 ± 0.82 1.49 ± 1.06 1.57 ± 1.17 0.001
HDL-c (mmol/L) 1.24 ± 0.31 1.23 ± 0.27 1.22 ± 0.28 1.23 ± 0.31 0.502
LDL-c (mmol/L) 3.07 ± 0.75 2.98 ± 0.71 3.01 ± 0.72 3.03 ± 0.78 0.153
hs-CRP (mg/L) 1.23 (0.94-1.84) 1.21 (0.93-1.87) 1.24 (0.94-1.84) 1.32 (0.99-2.02) 0.022
LXA4 (ng/mL) 1.22 (0.97-1.41) 1.90 (1.73-2.06) 2.69 (2.45-2.94) 4.78 (3.91-7.43) < 0.001
TyG 8.56 ± 0.54 8.55 ± 0.52 8.61 ± 0.56 8.64 ± 0.59 0.010
TG/HDL-c 2.20 (1.40-3.53) 2.20 (1.44-3.45) 2.32 (1.51-3.80) 2.32 (1.51-3.80) 0.033

Data are presented as means ± SD, medians (IQR), or n(%).

Significant data in the table are in bold.